BOBBI DARR: Open Payments
NPI 1659756377 · ORANGE CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$947 in 41 payments from 11 companies in 2025. Trend: 2023 $1,420 · 2024 $491 · 2025 $947
Food & beverage: $875Education: $72
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 19 | $438 |
| Janssen Biotech, Inc. | 6 | $150 |
| Novartis Pharmaceuticals Corporation | 4 | $99 |
| GENZYME CORPORATION | 2 | $54 |
| ABBVIE INC. | 2 | $51 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| Amgen Inc. | 2 | $36 |
| LEO Pharma Inc. | 1 | $26 |
| Journey Medical Corporation | 1 | $25 |
| Galderma Laboratories, L.P. | 1 | $14 |
Products named: Bimzelx, TREMFYA, COSENTYX, DUPIXENT, Sotyktu, Otezla, SKYRIZI, ADBRY.
Industry payments across FL — which companies pay providers there.
